Navigation Links
Spheris Reports First Quarter 2009 Results
Date:5/13/2009

FRANKLIN, Tenn., May 13 /PRNewswire/ -- Spheris, a leading global provider of clinical documentation technology and services, today announced results for the three months ended March 31, 2009.

Financial Highlights--First Quarter of 2009

Net revenues for the first quarter of 2009 were $41.8 million compared with $49.3 million in the first quarter of 2008. The $7.5 million decrease in net revenues during the first quarter of 2009 compared with the prior-year period was due primarily to the impact of net lost business and lower average contract pricing.

Operating income for the first quarter of 2009 was $4.6 million, or 11.0% of net revenues, compared with an operating loss of $0.7 million, or 1.4% of net revenues, during the prior-year period. The increase in operating income during the first quarter of 2009 compared with the prior-year period was due largely to improved operating margins associated with increased utilization of the Company's global production workforce and speech recognition technologies. These cost improvements more than offset the impact from lower revenues as noted above. Additionally, general and administrative expenses were lower in 2009 versus 2008 due to $1.3 million of expenses recognized in the first quarter of 2008 relating to a transaction that was not consummated, as well as lower overhead costs in 2009 associated with Company restructuring efforts. Operating income for the first quarter of 2009 also improved versus the prior year period due to $4.2 million less depreciation and amortization expense associated with customer list assets that were fully amortized during 2008.

The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, other expense or income, and restructuring charges. Adjusted EBITDA for the Company was $7.0 million, or 16.7% of net revenues, in the first quarter of 2009 compared with $5.2 million, or 10.5% of net revenues, in the prior-year period. The increase in Adjusted EBITDA in the first quarter of 2009 compared with the prior-year period was due to the operating income improvements described above, excluding the impact of the lower depreciation and amortization expense.

Adjusted EBITDA is a financial measure not computed in accordance with United States generally accepted accounting principles, or GAAP. Please refer to the "Supplemental Financial Information" and related note contained in this press release for further discussion and reconciliation of Adjusted EBITDA to GAAP financial measures.

Commenting on the first quarter 2009 results, Daniel J. Kohl, president and chief executive officer of Spheris, stated, "We made progress in the quarter with the initiatives to get Spheris back on track. The first quarter results are encouraging and reflect the benefit of cost reduction efforts as well as efficiencies from utilizing speech recognition and global production capabilities. However, this is only the start to what we expect will be a very challenging year."

Balance Sheet Highlights

As of March 31, 2009, the outstanding indebtedness under the Company's senior secured credit facility was $75.2 million and the outstanding indebtedness under the Company's senior subordinated notes was $125.0 million.

Liquidity Highlights

As of March 31, 2009, Spheris held $9.9 million in unrestricted cash and cash equivalents. During the first quarter of 2009, the Company generated cash from operating activities of $6.9 million compared with $2.2 million of cash used in operating activities during the same period in 2008. The $9.1 million period over period improvement in cash from operating activities was primarily attributable to changes in working capital items including: (a) changes in accrued wages and benefits resulting from the timing of bi-weekly payrolls, and bonus payments made in the first quarter of 2008 that were not paid during 2009; (b) timing of receivables collections; and (c) timing of payables disbursements. Cash provided by operating activities was also higher during the first quarter of 2009 due to the increase in Adjusted EBITDA as described above.

Investor Conference Call and Webcast

Spheris will host a conference call on Thursday, May 14, 2009, at 8 a.m. CT. The number to call for this interactive teleconference is (480) 629-9786. Following the conference call, the audio replay will be available for one week by dialing (303) 590-3030 and entering the confirmation number 4060239. The live broadcast of Spheris' quarterly conference call will be available online at www.spheris.com and http://www.videonewswire.com/event.asp?id=58013 on Thursday, May 14, 2009, at 8 a.m. CT. The online replay will be available shortly after the call and will continue for 30 days.

About Spheris

Spheris is a leading global provider of clinical documentation technology and services to health systems, hospitals and group practices throughout the U.S. Spheris offers a highly advanced, Web-based technology platform blended with Spheris' outsource services. Spheris employs approximately 4,500 skilled medical language specialists supporting the Company's clients through a secure network. Using a Follow the Sun(SM) service strategy, customer support is provided 24 hours a day, 365 days a year with an emphasis on verifiable quality, turnaround time and pricing. Spheris' corporate headquarters are located in Franklin, Tenn. For more information, please visit www.spheris.com.

Forward-Looking Statements

This press release contains statements as to the Company's beliefs and expectations of the outcome of future events that are forward-looking statements as defined within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties as described in the filings made from time to time by the Company with the Securities and Exchange Commission, including, without limitation, the following: (i) the effect our substantial indebtedness has on our ability to raise additional capital to fund our business, to react to changes in the economy or our business and to fulfill our obligations under our indebtedness, including our ability to meet financial covenants and other conditions of our senior secured credit facility and indenture governing our senior subordinated notes; (ii) the recent global economic and financial market crisis has had and may continue to have a negative impact on our business and results of operations; (iii) capital markets are currently experiencing a period of dislocation and instability, which has had and could continue to have a negative impact on the availability and cost of capital; (iv) our history of losses and accumulated deficit; (v) our ability to effectively manage our global production capacity, including our ability to recruit, train and retain qualified medical language specialists and maintain high standards of quality service in our operations; (vi) our ability to support existing technologies as well as adapt and integrate new technology into our clinical documentation platforms to improve our production capabilities and expand the breadth of our technology and service offerings; (vii) our ability to maintain our competitive position against current and future competitors, including our ability to gain new business with acceptable operating margins and ongoing price pressures related to our technology and services and the healthcare markets in general; (viii) the reluctance of potential customers to outsource or change providers of their clinical documentation technology and services and its impact on our ability to attract new customers and increase revenues; (ix) financial and operational risks inherent in our global operations, including foreign currency exchange rate fluctuations and transfer pricing laws between the United States and India; (x) our ability to attract, hire or retain technical and managerial personnel necessary to develop and implement technology and services to our customers; (xi) the effect on our business if we incur additional debt and assume contingent liabilities and expenses in connection with future acquisitions or if we cannot effectively integrate newly acquired operations; and (xii) our ability to adequately protect our intellectual property rights, including our proprietary technology and the intellectual property we license from third parties.

The Company takes no responsibility for updating the information contained in this press release following the date hereof to reflect events or circumstances occurring after the date hereof or the occurrence of unanticipated events or for any changes or modifications made to this press release.

                                      SPHERIS INC.
                   Condensed Consolidated Statements of Operations
                                (Amounts in Thousands)

                                                    (Unaudited)
                                             Three Months Ended March 31,
                                                  2009              2008
    Net revenues                               $41,849           $49,270

    Operating expenses:
       Direct costs of revenues
        (exclusive of depreciation and
        amortization below)                     28,574            36,422
       Marketing and selling expenses              611             1,310
       General and administrative
        expenses                                 5,628             6,355
       Depreciation and amortization             1,772             5,910
       Restructuring charges                       689                 -
        Total operating costs                   37,274            49,997

             Operating income (loss)             4,575              (727)

    Interest expense, net of income              4,370             4,930
    Other (income) expense                      (1,056)            1,354
        Net income (loss) before income
         taxes                                   1,261            (7,011)

    Provision for (benefit from)
     income taxes                                  354            (2,188)

             Net income (loss)                    $907           $(4,823)



                                         SPHERIS INC.
                            Condensed Consolidated Balance Sheets
                          (Amounts in Thousands, Except Share Amounts)

                                              (Unaudited)
                                            March 31, 2009  December 31, 2008

    Assets
    Current assets
      Unrestricted cash and cash
       equivalents                                $9,929          $3,262
      Restricted cash                              1,197             309
      Accounts receivable, net of
       allowance of $915 and
       $1,332, respectively                       28,465          28,510
      Deferred taxes                                 353             372
      Prepaid expenses and other
       current assets                              4,556           4,430
          Total current assets                    44,500          36,883

    Property and equipment, net                   11,848          12,309
    Internal-use software, net                     1,286           1,586
    Goodwill                                     218,841         218,841
    Other noncurrent assets                        5,490           5,459
          Total assets                          $281,965        $275,078

    Liabilities and stockholders'
     equity
    Current liabilities
      Accounts payable                            $2,928          $2,893
      Accrued wages and benefits                  10,432           8,545
      Current portion of long-term
       debt and lease obligations                    297             683
      Other current liabilities                    8,804           5,327
          Total current liabilities               22,461          17,448

    Long-term debt and lease
     obligations, net of current
     portion
                                                 197,998         195,499
    Deferred tax liabilities                         356             300
    Other long-term liabilities                    5,294           5,710
          Total liabilities                      226,109         218,957

    Common stock, $0.01 par value, 100 shares
     authorized, 10 shares issued
     and outstanding                                   -               -
    Other comprehensive loss                      (2,563)         (1,344)
    Contributed capital                          111,727         111,680
    Accumulated deficit                          (53,308)        (54,215)
          Total stockholders' equity              55,856          56,121

             Total liabilities and
              stockholders' equity              $281,965        $275,078



                                          SPHERIS INC.
                       Condensed Consolidated Statements of Cash Flows
                                   (Amounts in Thousands)

                                                         (Unaudited)
                                                  Three Months Ended March 31,
                                                      2009              2008

     Cash flows from operating activities:
     Net income (loss)                                $907           $(4,823)
     Adjustments to reconcile net income
      (loss) to net cash provided by (used in)
      operating activities:
        Depreciation and amortization                1,772             5,910
        Amortization of acquired technology              -               162
        Deferred taxes                                  75            (2,168)
        Change in fair value of derivative
         financial instruments                        (527)            1,255
        Amortization of debt discounts and
         issuance costs                                228               153
        Other non-cash items                            69               170
        Changes in operating assets and
         liabilities, net of acquisitions:
          Accounts receivable                           45              (876)
          Prepaid expenses and other current
           assets                                   (1,014)             (846)
          Accounts payable                             141              (713)
          Accrued wages and benefits                 1,887            (4,185)
          Other current liabilities                  3,467             4,176
          Other noncurrent assets and
           liabilities                                (111)             (386)
             Net cash provided by (used in)
              operating activities                   6,939            (2,171)

     Cash flows from investing activities:
     Purchases of property and equipment              (868)           (1,272)
     Purchases and development of
      internal-use software                           (156)             (165)
             Net cash used in investing activities  (1,024)           (1,437)

     Cash flows from financing activities:
     Proceeds from debt                              2,500                 -
     Payments on debt and lease obligations           (529)              (16)
             Net cash provided by (used in)
              financing activities                   1,971               (16)

     Effect of exchange rate change on cash
      and cash equivalents                          (1,219)              162
     Net increase (decrease) in
      unrestricted cash and cash
      equivalents                                    6,667            (3,462)
     Unrestricted cash and cash
      equivalents, at beginning of period            3,262             7,195
     Unrestricted cash and cash
      equivalents, at end of period                 $9,929            $3,733



                                          SPHERIS INC.
                              Supplemental Financial Information
                                   (Amounts in Thousands)

                                                      (Unaudited)
                                              Three Months Ended March 31,
                                                 2009              2008

    Net income (loss)                             $907           $(4,823)
    Depreciation and amortization                1,772             5,910
    Interest expense, net of income              4,370             4,930

    Other (income) expense                      (1,056)            1,354
    Restructuring charges.                         689                 -
    Provision for (benefit from) income taxes      354            (2,188)

             Adjusted EBITDA                    $7,036            $5,183
                  

Note to Supplemental Financial Information

The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, other expense or income (including mark-to-market adjustments related to the Company's derivative financial instruments), and restructuring charges. Adjusted EBITDA is a financial measure not computed in accordance with United States generally accepted accounting principles, or GAAP. The Company believes that this non-GAAP measure, when presented in conjunction with the comparable GAAP measure, is useful to both management and investors in analyzing the Company's ongoing business and operating performance. The Company believes that providing the non-GAAP information to investors, in addition to the GAAP presentation, allows investors to view the Company's financial results in the way management and the Company's senior lenders view the Company's operating results. Management believes Adjusted EBITDA is useful as a supplemental measure of the performance of the Company's operations because it isolates the Company's operating performance from the accounting impact of the Company's financing strategies, tax provisions, and depreciation and amortization. Additionally, since Adjusted EBITDA is a significant component of certain financial covenants under the Company's senior secured credit facility agreement, management believes Adjusted EBITDA is useful for investors to better assess the Company's compliance with these financial covenants. Management believes Adjusted EBITDA should be considered in addition to, but not as a substitute for, items prepared in accordance with GAAP that are presented in this press release, as the items excluded in the presentation of Adjusted EBITDA are significant components in understanding and assessing financial performance. A reconciliation of Adjusted EBITDA to the nearest comparable GAAP financial measure is provided above. Adjusted EBITDA, as presented, may not be comparable to similarly titled measures of other companies.


'/>"/>
SOURCE Spheris
Copyright©2009 PR Newswire.
All rights reserved


Related medicine news :

1. Spheris Sets First Quarter 2009 Earnings Release And Conference Call Dates
2. Spheris Reports Fourth Quarter and Year-End 2008 Results
3. Spheris Sets Fourth Quarter 2008 Earnings Release and Conference Call Dates
4. Spheris Reports Third Quarter 2008 Results
5. Spheris Reports Fourth Quarter and Year-End 2007 Results
6. Spheris Sets Fourth Quarter 2007 Earnings Release and Conference Call Dates
7. Spheris Elects New Board Member
8. Whole Foods Market Reports Second Quarter 2009 Results
9. Winner Medical Reports Second Quarter Fiscal 2009 Results
10. Actuaries: Trustees Reports Warn of Looming Financial Challenges Facing Retirement Programs
11. Pharmos Corporation Reports 2009 First Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
(Date:6/24/2016)... Rhinebeck, NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of ... of companies that call for a minimum wage raise to $12 an hour by 2020 ... wage. This will restore the lost value of the minimum wage, assure the wage floor ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... The Grove Investment Group (TGIG), has initiated cultivation and processing operations at its ... Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... addition of the "Structural Electronics 2015-2025: Applications, ... In-Mold Electronics, Smart ... Integrated Photovoltaics Structural electronics involves ... as load-bearing, protective structures, replacing dumb structures such ...
(Date:6/24/2016)... June 24, 2016 Dehaier Medical Systems Ltd. ... which develops, markets and sells medical devices and wearable ... signed a strategic cooperation agreement with Hongyuan Supply Chain ... Chain") on June 20, 2016, to develop Dehaier,s new ... cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s sales ...
(Date:6/24/2016)... -- Research and Markets has announced the addition ... report to their offering. ... The World Market for Companion Diagnostics covers the world ... in the report includes the following: , ... by Region (N. America, EU, ROW), 2015-2020 , World ...
Breaking Medicine Technology: